Lili Cheng

发表

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Jianyang Zeng, Ligong Chen, Z. Miao, 2020, bioRxiv.

Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening.

A. Schlessinger, Hailin Hu, Ligong Chen, 2016, ACS chemical biology.

Ablation of H+/glucose Exporter SLC45A2 Enhances Melanosomal Glycolysis to Inhibit Melanin Biosynthesis and Promote Melanoma Metastasis.

Ligong Chen, Lei Tao, P. Jiang, 2022, The Journal of investigative dermatology.

Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity

J. Chen, Ligong Chen, J. Siegenthaler, 2017, Scientific Reports.

mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis

M. Huang, Ligong Chen, F. Wang, 2019, Cell Death & Differentiation.

Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue

Ligong Chen, K. Giacomini, S. Yee, 2019, PLoS biology.

A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis

Ligong Chen, Xin Chen, A. Cossu, 2017 .

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Jianyang Zeng, Ligong Chen, Z. Miao, 2021, Signal Transduction and Targeted Therapy.

A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis

D. Calvisi, Ligong Chen, Xin Chen, 2017, Hepatology.

Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity

Ligong Chen, Xiaoyu Hu, J. Siegenthaler, 2017, Archives of Toxicology.

SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility

Ligong Chen, Lili Cheng, Xiaohui Liu, 2020, Cell reports.

Discovery of Imidazo[1,2-α][1,8]naphthyridine Derivatives as Potential HCV Entry Inhibitor.

Ligong Chen, Yefeng Tang, Jie Qing, 2015, ACS medicinal chemistry letters.

Hepatic mitochondrial NAD+ transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis

Jiandie D. Lin, Lei Tao, Lili Cheng, 2023, Hepatology.

Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening.

A. Schlessinger, Hailin Hu, Ligong Chen, 2016, ACS chemical biology.

MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation

Lili Cheng, Ye Liu, Wenna Chi, 2024, Nature communications.

mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis

Ligong Chen, F. Wang, Hongbing Zhang, 2019, Cell Death & Differentiation.

Discovery of Imidazo[1,2-α][1,8]naphthyridine Derivatives as Potential HCV Entry Inhibitor.

Ligong Chen, Yefeng Tang, Jie Qing, 2015, ACS medicinal chemistry letters.